![]() Oxford Nanopore Technologies Oxford Nanopore Technologies is a company that develops nanopore-based electronic systems for the analysis of single molecules. | Illumina Illumina is a company that develops, manufactures, and markets life science tools and sequencing and array-based integrated systems for genetic and genomic analysis. | ![]() 10X Genomics 10X Genomics is a company building products for research institutions and pharmaceutical companies across the life sciences, including oncology, immunology, and neuroscience. | ![]() Pacific Biosciences of California Pacific Biosciences of California (PacBio, formerly known as Nanofluidics) is a company developing a platform for genetic analysis. | ![]() Complete Genomics Complete Genomics is a company that develops sequencing solutions for laboratories. | |
Founding Date | Founding Date 2005 | Founding Date 1998 | Founding Date 2012 | Founding Date 2004 | Founding Date 2005 |
Type | Type Public | Type Public | Type Public | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations San Diego, US HQ Melbourne, AU Wien, AT Mechelen, BE Sao Paulo, BR Vancouver, CA Beijing, CN see more | Locations Pleasanton, US HQ Shanghai, CN Leiden, NL Singapore, SG San Francisco, US | Locations Menlo Park, US HQ Shanghai, CN Yokohama, JP Seoul, KR Singapore, SG London, GB Baltimore, US see more | Locations San Jose, US HQ | |
Employees | Employees 1,382 | Employees 8,6004% decrease | Employees 1,17810% decrease | Employees 48516% decrease | Employees 2361% decrease |
Valuation ($) | Valuation ($) 1.8 b | Valuation ($) 23.3 b | Valuation ($) 1.9 b | Valuation ($) 561.4 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) £223.9m (FY, 2025) | Revenue (est.) $4.3b (FY, 2025) | Revenue (est.) $642.8m (FY, 2025) | Revenue (est.) $160m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods £42.8m (FY, 2025) | Cost of goods $1.5b (FY, 2025) | Cost of goods $198.9m (FY, 2025) | Cost of goods $114.2m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit £181.1m (FY, 2025) | Gross profit $2.9b (FY, 2025) | Gross profit $443.9m (FY, 2025) | Gross profit $45.8m (FY, 2025) | Gross profit N/A |
Net income | Net income (£145.2m) (FY, 2025) | Net income $850m (FY, 2025) | Net income ($43.5m) (FY, 2025) | Net income ($546.4m) (FY, 2025) | Net income N/A |
Operating ⚠ | |||||
Countries | Countries 120 (FY, 2021) | Countries N/A | Countries 40 (FY, 2019) | Countries N/A | Countries N/A |
Funding | |||||
Total funding raised | Total funding raised $ 1.3b | Total funding raised $ 28m | Total funding raised $ 195.5m | Total funding raised $ 681.9m | Total funding raised $ 143m |
Illumina is a company that develops, manufactures, and markets life science tools and sequencing and array-based integrated systems for genetic and genomic analysis.
View company
10X Genomics is a company building products for research institutions and pharmaceutical companies across the life sciences, including oncology, immunology, and neuroscience.
View company
Pacific Biosciences of California (PacBio, formerly known as Nanofluidics) is a company developing a platform for genetic analysis.
View company
Complete Genomics is a company that develops sequencing solutions for laboratories.
View company